このエピソードについて
In this episode of the Driving the Business of Science podcast, host Keith Parent, CEO of Court Square Group, interviews Mitchell Bayer, Managing Principal of Arlen Consulting Group, about the evolution of the life science industry and the role of CROs. Mitch discusses his 24-year career, starting at Medidata, where he spearheaded the ASPire to Win™ CRO partner program, which grew to 16 partners by 2009. He emphasizes the importance of integrating technology with CROs to enhance competitiveness and efficiency. Mitch highlights the shift from paper-based trials to electronic data capture (EDC) and the potential of AI in streamlining clinical trials. He also discusses the importance of technology that integrates seamlessly with existing systems and reduces site burden.
Driving the Business of Science is the podcast for clinical operations, IT, and business managers in the pharma, biotech, and medical device world.
Bringing new products to market takes more than just great science. From R&D and clinical to regulatory and approval life science leaders require fit-for-purpose technology, processes, and partners at step.
In the Driving the Business of Science podcast leaders from across the life science industry share real-world experiences and practical insights that will impact your business.
Join host Keith Parent, serial life science CEO, as business leaders share experiences and insights on emerging challenges in the life science market.
